Alembic Pharmaceuticals informs about updates

11 Oct 2021 Evaluate

Alembic Pharmaceuticals has informed that the Company has received Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for the inspection carried out by them at its New Injectable Facility (F-3) at Karakhadi during the period from 28th January, 2021 to 6th February, 2021, indicating that the USFDA finds its responses to their observations to be adequate. USFDA has also indicated that a compliance verification would be performed during re-inspection of the said Facility in the next review cycle.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

838.15 -5.00 (-0.59%)
30-Dec-2025 10:52 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1266.95
Cipla 1483.85
Zydus Lifesciences 901.65
Lupin 2078.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×